Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as ...

Therefore, Cognizant Technology Solutions has an ROCE of 18%. In absolute terms, that's a satisfactory return, but compared to the IT industry average of 11% it's much better.

Fifth Third Bancorp trimmed its holdings in shares of Cognizant Technology Solutions Co. (NASDAQ:CTSH – Free Report) by 2.6% ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

The testimony of Srimanikandan Ramamoorthy, dubbed the essential witness by the US Department of Justice, is critical, ...

Cognizant Technology Solutions (NASDAQ:CTSH – Get Free Report) is expected to issue its quarterly earnings data after the market closes on Wednesday, February 5th. Analysts expect the company to ...

Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...

Cognizant Technology Solutions Corp (CTSH) stock saw a modest uptick, ending the day at $81.12 which represents a slight increase of $1.07 or 1.34% from the prior close of $80.05. The stock opened at ...

Cognizant sued Infosys, accusing it of stealing secrets related to its US subsidiary TriZetto's healthcare insurance software ...

We recently compiled a list of the Top 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to ...

A US court has requested Cognizant to specify the nature of its trade secrets after Infosys denied the theft allegations, ...

The row between the two IT services firms arose in August 2024 when Cognizant alleged that Infosys stole trade secrets of its software products used to process insurance claims in the healthcare ...